Your browser doesn't support javascript.
loading
The Effect of the Drug Medi-Cal Organized Delivery System 1115 Demonstration Waiver on Substance Use Disorder Treatment Access: Evidence from California.
Bass, Brittany; Urada, Darren; Khurana, Dhruv; Boustead, Anne; Joshi, Vandana.
Afiliação
  • Bass B; University of California, Los Angeles, Integrated Substance Abuse Programs, United States. Electronic address: bbass@mednet.ucla.edu.
  • Urada D; University of California, Los Angeles, Integrated Substance Abuse Programs, United States.
  • Khurana D; University of California, Los Angeles, Integrated Substance Abuse Programs, United States.
  • Boustead A; University of Arizona, School of Government and Public Policy, United States.
  • Joshi V; University of California, Los Angeles, Integrated Substance Abuse Programs, United States.
Drug Alcohol Depend ; 246: 109847, 2023 05 01.
Article em En | MEDLINE | ID: mdl-37001321
BACKGROUND: In August 2015, the California Department of Health Care Services created the Drug Medi-Cal Organized Delivery System 1115 demonstration waiver (DMC-ODS waiver) to improve service delivery to Medi-Cal-eligible individuals with a substance use disorder (SUD). We examine if implementing the DMC-ODS waiver across California counties improved patient access to SUD treatment services. METHODS: We use administrative data from 2016 to 2020 from a reporting system for all publicly-funded SUD treatment services delivered in California and employ difference-in-differences and event study empirical strategies exploiting the differential timing of DMC-ODS waiver adoption across counties. RESULTS: Event study analyses show that eleven or more months after the introduction of the DMC-ODS waiver, the number of unique patient admissions significantly increase by nearly 20%. Residential treatment admissions significantly increase by roughly 25% in all months post-waiver introduction. CONCLUSIONS: This study provides valuable information for policymakers about implementing 1115 waivers, and the important public health implications. California's DMC-ODS waiver has demonstrated that 1115 waivers similar to it can likely increase access to SUD treatment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicaid Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicaid Limite: Humans País/Região como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article